Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice

Molecular and Cellular Biology

Volumn 19, Issue 6, 1999, Pages 4443-4451

  Smith, Kevin S ^a   Rhee, Joon Whan ^a   Naumovski, Louie ^a   Cleary, Michael L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; HEPATIC LEUKEMIA FACTOR; HYBRID PROTEIN; LEUCINE ZIPPER PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; LYMPHOMA; MALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE; THYMUS DISEASE; TRANSGENIC MOUSE;

EID: 0344348920     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.6.4443     Document Type: Article

References (46)

1. Ardavin, C., L. Wu, C. L. Li, and K. Shortman. 1993. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature 362:761-763.
2. Aronheim, A., R. Shiran, A. Rosen, and M. D. Walker. 1993. The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc. Natl. Acad. Sci. USA 90:8063-8067.
3. Bain, G., I. Engel, E. C. Robanus Maandag, H. P. J. te Riele, J. R. Voland, L. L. Sharp, J. Chun, B. Huey, D. Pinkel, and C. Murre. 1997. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17:4782-4791.
4. Bain, G., and C. Murre. 1998. The role of E-proteins in B- and T-lymphocyte development. Semin. Immunol. 10:143-153.
5. Bindl, J. M., and R. A. Warnke. 1986. Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in coplin jars. Am. J. Pathol. 85:490-493.
6. Brady, H. J., G. Gil-Gomez, J. Kirberg, and A. J. Berns. 1996. Bax alpha perturbs T cell development and affects cell cycle entry of T cells. EMBO J. 15:6991-7001.
7. Cleary, M. L., S. D. Smith, and J. Sklar. 1986. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28.
8. Cleary, M. L. 1991. Oncogenic conversion of transcription factors by chromosomal translocations. Cell 66:619-622.
9. Dedera, D. A., E. K. Waller, D. P. LeBrun, A. Sen-Majumbar, M. E. Stevens, G. S. Barsh, and M. L. Cleary. 1993. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell 74:833-843.
10. Hatano, M., C. W. M. Roberts, T. Kawabe, J. Shutter, and S. J. Korsmeyer. 1992. Cell cycle progression, and cell death and T cell lymphoma in hox11 transgenic mice. Blood 80(Suppl. 1):335A. (Abstract.)
11. 10a. Hitzler, J. K., H. D. Soares, D. W. Drolet, T. Inaba, S. O'Connel, M. G. Rosenfeld, J. I. Morgan, and A. T. Look. 1999. Expression patterns of the hepatic leukemia factor gene in the nervous system of developing and adult mice. Brain Res. 820:1-11.
12. Hogan, B., F. Constantini, and E. Lacy. 1986. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
13. Hunger, S. P., K. Ohyashiki, K. Toyama, and M. L. Cleary. 1992. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev. 6:1608-1620.
14. Hunger, S. P., and M. L. Cleary. 1993. Chimaeric oncoproteins resulting from chromosomal translocations in acute lymphoblastic leukemia. Semin. Cancer Biol. 4:387-399.
15. Hunger, S. P., R. Brown, and M. L. Cleary. 1994. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF. Mol. Cell. Biol. 14:5986-5996.
16. Hunger, S. P., P. E. Devaraj, L. Foroni, L. M. Seeker-Walker, and M. L. Cleary. 1994. Two type of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL. Blood 83:2970-2977.
17. Hunger, S. P. 1996. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood 87:1211-1224.
18. Hunger, S. P., S. Li, M. Z. Fall, L. Naumovski, and M. L. Cleary. 1996. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties. Blood 87:4607-4617.
19. Ikushima, S., T. Inukai, T. Inaba, S. D. Nimer, J. L. Cleveland, and A. T. Look. 1997. Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes. Proc. Natl. Acad. Sci. USA 94:2609-2614.
20. Inaba, T., W. M. Roberts, L. H. Shapiro, K. W. Jolly, S. C. Raimondi, S. D. Smith, and A. T. Look. 1992. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257:531-534.
21. Inaba, T., L. H. Shapiro, T. Funabiki, A. E. Sinclair, B. G. Jones, R. A. Ashmun, and A. T. Look. 1994. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein. Mol. Cell. Biol. 14:3403-3413.
22. Inaba, T., T. Inukai, T. Yoshihara, H. Seyschab, R. A. Ashmun, C. E. Canman, S. J. Laken, M. B. Kastan, and A. T. Look. 1996. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor. Nature 382:541-544.
23. Inukai, T., T. Inaba, T. Yoshihara, and A. T. Look. 1997. Cell transformation mediated by homodimeric E2A-HLF transcription factors. Mol. Cell. Biol. 17:1417-1424.
24. Inukai, T., T. Inaba, S. Ikushima, and A. T. Look. 1998. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF. Mol. Cell. Biol. 18:6035-6043.
25. Jacobs, Y., C. Vierra, and C. Nelson. 1993. E2A expression, nuclear localization, and in vivo formation of DNA- and non-DNA-binding species during B-cell development. Mol. Cell. Biol. 13:7321-7333.
26. Knudson, C. M., and S. J. Korsmeyer. 1997. Bcl-2 and Bax function independently to regulate cell death. Nat. Genet. 16:358-363.
27. Langdon, W. Y., A. W. Harris, S. Cory, and J. M. Adams. 1986. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell 47:11-18.
28. Larson, R. C., P. Fisch, T. A. Larson, I. Lavenir, T. Langford, G. King, and T. H. Rabbitts. 1994. T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene 9:3675-3681.
29. Larson, R. C., I. Lavenir, T. A. Larson, R. Baer, A. J. Warren, I. Wadman, K. Nottage, and T. H. Rabbitts. 1996. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J. 15:1021-1027.
30. Look, A. T. 1997. Oncogenic transcription factors in the human acute leukemias. Science 278:1059-1064.
31. Look, A. T. 1997. E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastic leukemia. Curr. Top. Microbiol. Immunol. 220:45-53.
32. Ma, A., J. C. Pena, B. Chang, E. Margosian, L. Davidson, F. W. Alt, and C. B. Thompson. 1995. Bclx regulates the survival of double-positive thymocytes. Proc. Natl. Acad. Sci. USA 92:4763-4767.
33. McGuire, E. A., C. E. Rintoul, G. M. Sclar, and S. J. Korsmeyer. 1992. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma. Mol. Cell. Biol. 12:4186-4196.
34. Metzstein, M. M., M. O. Hengartner, N. Tsung, R. E. Ellis, and H. R. Horvitz. 1996. Transcriptional regulator of programmed cell death encoded by Caenorhabditis elegans gene ces-2. Nature 382:545-547.
35. Moore, T. A., and A. Zlotnik. 1995. T-cell lineage commitment and cytokine responses of thymic progenitors. Blood 86:1850-1860.
36. Motoyama, N., F. Wang, K. A. Roth, H. Sawa, K. Nakayama, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, and D. Y. Loh. 1995. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1505-1510.
37. Newcombe, K., T. Glassco, and C. Mueller. 1998. Regulation of the DBP promoter by PAR proteins and in leukemic cells bearing an E2A-HLF translocation. Biochem. Biophys. Res. Commun. 17:633-639.
38. Ohyashiki, K., H. Fujieda, J. Miyauchi, J. H. Ohyashiki, T. Tauchi, M. Saito, S. Nakazawa, K. Abe, K. Yamamoto, S. C. Clark, and K. Toyama. 1991. Establishment of a novel heterotransplantable acute lymphoblastic leukemia cell line with a t(17;19) chromosomal translocation the growth of which is inhibited by interleukin-1. Leukemia 5:322-331.
39. Quong, M. W., M. E. Massari, R. Zwart, and C. Murre. 1993. A new transcriptional-activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol. Cell. Biol. 13:792-800.
40. Smith, K. S., Y. Jacobs, C.-P. Chang, and M. L. Cleary. 1997. Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2. Oncogene 14:2917-2926.
41. Smith, K. S., J. W. Rhee, and M. L. Cleary. Unpublished observations.
42. Strasser, A., A. W. Harris, D. L. Vaux, E. Webb, M. L. Bath, J. M. Adams, and S. Cory. 1990. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr. Top. Microbiol. Immunol. 166:175-181.
43. Veis, D. J., C. M. Sorenson, J. R. Shutter, and S. J. Korsmeyer. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240.
44. Wu, L., R. Scollay, M. Egerton, M. Pearse, G. J. Spangrude, and K. Shortman. 1991. CD4 expressed on earliest T-lineage precursor cells in the adult murine thymus. Nature 349:71-74.
45. Yan, W., A. Z. Young, V. C. Soares, R. Kelley, R. Benezra, and Y. Zhuang. 1997. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17:7317-7327.
46. Yoshihara, T., T. Inaba, L. H. Shapiro, J. Y. Kato, and A. T. Look. 1995. E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF. Mol. Cell. Biol. 15:3247-3255.